Correction: Ruxolitinib sensitizes ovarian cancer to reduced dose Taxol, limits tumor growth and improves survival in immune competent mice

Detalles Bibliográficos
Autores principales: Reeves, Patrick M., Abbaslou, Mojgan A., Kools, Farah R.W., Vutipongsatorn, Kritchai, Tong, Xiaoyun, Gavegnano, Christina, Schinazi, Raymond F., Poznansky, Mark C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6084395/
https://www.ncbi.nlm.nih.gov/pubmed/30101001
http://dx.doi.org/10.18632/oncotarget.25791

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6084395/
https://www.ncbi.nlm.nih.gov/pubmed/30101001
http://dx.doi.org/10.18632/oncotarget.25791

Ejemplares similares